Removing STING-mediated chemokine induction from the equation by treating Brca2 knockout tumours unresponsive to STING activation resulted in survival benefits that recapitulated the dose-dependent dynamic of cell cytotoxicity by synthetic lethality. This evidence concerns the gene STING1 and neoplasm.